Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

14

Number of overlapping holdings

66.7%

% of OZEM's 22 holdings also in THNR

60.9%

% of THNR's 23 holdings also in OZEM

Overlap by Weight
Sector Drift (OZEM minus THNR)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in OZEM
Weight
in THNR
Overlap
ELI LILLY & CO 16.9% 17.3% 16.9%
NOVO-NORDISK A/S-SPONS ADR 16.2% 12.6% 12.6%
ROCHE HOLDING LTD 4.9% 5.0% 4.9%
CHUGAI PHARMACEUTICAL CO LTD 4.7% 6.1% 4.7%
INNOVENT BIOLOGICS, INC. 3.6% 5.5% 3.6%

Position Highlights (Non-Overlapping Exposures)
OZEM Overweight Relative to THNR
NOVO-NORDISK A/S-SPONS ADR 3.6%
ALTIMMUNE, INC. 3.4%
TERNS PHARMACEUTICALS, INC. 2.8%
VIKING THERAPEUTICS, INC. 2.6%
HANMI PHARM CO LTD 2.5%
REGENERON PHARMACEUTICALS 2.3%
ZEALAND PHARMA A/S 2.3%
SCHOLAR ROCK HOLDING CORP. 2.2%
CHINA PHARMACEUTICAL GROUP 2.0%
SHIONOGI & CO LTD 1.9%
OZEM Underweight Relative to THNR
WEST PHARMACEUTICAL SERVICES -5.0%
THERMO FISHER SCIENTIFIC INC -4.7%
TEVA PHARMACEUTICAL-SP ADR -4.6%
MERCK & CO. INC. -4.5%
HIMS & HERS HEALTH, INC. CLASS A -3.7%
MITSUBISHI CHEMICAL HOLDINGS -3.5%
AMGEN INC -1.9%
INNOVENT BIOLOGICS, INC. -1.8%
ASTRAZENECA PLC-SPONS ADR -1.8%
GERRESHEIMER AG -1.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY